Inventor · disambiguated record
Stanley M. Crain
Also filed as: CRAIN STANLEY M
18 granted patents·11 pending applications·2,268 citations·filing 1993–2014
97Inventor score
Files withEINSTEIN COLL MED12CRAIN STANLEY M3PONDERA BIOTECHNOLOGIES LLC3PONDERA BIOTECHNOLOGIES INC2CRAIN STEVEN1
Top patents by PatentIndex Score
29 records- 0198US6096756AMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsEINSTEIN COLL MED·Filed 1998·Granted Aug 1, 2000·289 cites·7 claims
- 0297US7026329B2Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsEINSTEIN COLL MED·Filed 2002·Granted Apr 11, 2006·87 cites·49 claims
- 0397US6362194B1Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsEINSTEIN COLL MED·Filed 2000·Granted Mar 26, 2002·115 cites·31 claims
- 0497US5767125AMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsEINSTEIN COLL MED·Filed 1996·Granted Jun 16, 1998·211 cites·18 claims
- 0597US5512578AMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonistsEINSTEIN COLL MED·Filed 1994·Granted Apr 30, 1996·271 cites·32 claims
- 0697US5472943AMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonistsEINSTEIN COLL MED·Filed 1993·Granted Dec 5, 1995·293 cites·10 claims
- 0796US6395705B2Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonistsEINSTEIN COLL MED·Filed 2001·Granted May 28, 2002·122 cites·12 claims
- 0896US5580876AMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsEINSTEIN COLL MED·Filed 1995·Granted Dec 3, 1996·186 cites·29 claims
- 0995US6194382B1Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonistsEINSTEIN COLL MED·Filed 1999·Granted Feb 27, 2001·159 cites·15 claims
- 1093US6765010B2Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effectsPAIN THERAPEUTICS INC·Filed 2002·Granted Jul 20, 2004·100 cites·76 claims
- 1193US5624932AMethod for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addictionUNITED BIOMEDICAL INC·Filed 1995·Granted Apr 29, 1997·119 cites·8 claims
- 1292USRE36547EMethod of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonistsEINSTEIN COLL MED·Filed 1996·Granted Feb 1, 2000·121 cites·32 claims
- 1391US8741319B2Methods and compositions for treating anxiety disorders or symptoms thereofPONDERA BIOTECHNOLOGIES INC·Filed 2013·Granted Jun 3, 2014·23 cites·11 claims
- 1491US5585348AUse of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesiaEINSTEIN COLL MED·Filed 1993·Granted Dec 17, 1996·124 cites·8 claims
- 1588US8372414B2Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medicationsPONDERA BIOTECHNOLOGIES LLC·Filed 2012·Granted Feb 12, 2013·11 cites·6 claims
- 1688US8202525B2Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medicationsCRAIN STEVEN·Filed 2010·Granted Jun 19, 2012·16 cites·5 claims
- 1787US8617577B2Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medicationsPONDERA BIOTECHNOLOGIES LLC·Filed 2013·Granted Dec 31, 2013·9 cites·6 claims
- 1884US6737400B2Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonistsEINSTEIN COLL MED·Filed 2002·Granted May 18, 2004·12 cites·12 claims
- 1967US2005181974A1Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsFiled 2004·Application pending·0 cites
- 2065US2010015147A1Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-gangliosideCRAIN STANLEY M·Filed 2009·Application pending·0 cites
- 2163US2005101622A1Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonistsFiled 2004·Application pending·0 cites
- 2259US2014243363A1Methods and compositions for treating anxiety disorders or symptoms thereofPONDERA BIOTECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 2359US2010203084A1Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivatorCRAIN STANLEY M·Filed 2007·Application pending·0 cites
- 2453US2004087607A1Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-gangliosideFiled 2003·Application pending·0 cites
- 2551US2002137761A1Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally -acting opioid agonists by inhibiting GM1-gangliosideFiled 2002·Application pending·0 cites
- 2649US2002094947A1Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonistsFiled 2002·Application pending·0 cites
- 2748US2013197015A1Novel method to improve the safety and efficacy of caffeinePONDERA BIOTECHNOLOGIES LLC·Filed 2013·Application pending·0 cites
- 2848US2006052389A1Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effectsCRAIN STANLEY M·Filed 2004·Application pending·0 cites
- 2931US2001006967A1Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonistsFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →